News Agency
The Times

Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous Injection in China

  • Written by PR Newswire

YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) in China. This is an investigational ophthalmic drug developed by the group's subsidiary...

Read more: Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion